+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dyskinesia Market by Type, Treatment, Route of Administration, End User - Global Forecast 2025-2030- Product Image
Dyskinesia Market by Type, Treatment, Route of Administration, End User - Global Forecast 2025-2030- Product Image
Sale

Dyskinesia Market by Type, Treatment, Route of Administration, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6015563
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dyskinesia Market grew from USD 2.34 billion in 2023 to USD 2.50 billion in 2024. It is expected to continue growing at a CAGR of 8.44%, reaching USD 4.13 billion by 2030.

Dyskinesia refers to a disorder characterized by involuntary movements, often affecting patients with Parkinson’s disease or those undergoing long-term treatment with levodopa. The necessity for effective dyskinesia treatment is driven by the debilitating nature of the condition, which can significantly impair quality of life. Its application is primarily focused on pharmaceuticals and neurosurgical procedures aimed at managing symptoms and improving patient outcomes. The end-use scope includes hospitals, clinics, and research institutions actively engaged in neurology and patient care. The market is primarily influenced by factors such as an increasing global prevalence of Parkinson's disease, rising awareness, advancement in medical research, and increasing investments in healthcare infrastructure. Promising opportunities lie in the development of novel therapeutics and the adoption of cutting-edge technologies like deep brain stimulation and gene therapy. Pharmaceutical companies and biotechnological firms have the potential to lead innovation by developing drugs with enhanced efficacy and fewer side effects.

However, the market faces challenges such as high treatment costs, limited availability of therapies in remote regions, and stringent regulatory approval processes. These limitations could stall growth and delay the availability of efficient treatments. Counteractive measures include advocating for cost-effective therapeutic solutions and streamlining regulatory frameworks for faster approval processes. Areas ripe for innovation include personalized medicine, which could tailor treatments to individual genetic profiles, as well as digital health technologies that monitor patient symptoms and adjust treatments in real-time. Additionally, partnerships between pharmaceutical companies and tech firms could advance the integration of technology-driven solutions. The dyskinesia market is evolving, with robust research activities paving the way for breakthroughs. A strategic emphasis on collaboration, research investments, and technology adoption will fortify market positions and foster sustainable growth. Businesses that align with these innovation tracks stand to gain competitive advantages in a market that is both challenging and ripe with opportunity.

Understanding Market Dynamics in the Dyskinesia Market

The Dyskinesia Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Collaborative efforts between pharmaceutical companies and research institutions
    • Increase in patient-centric care models enhancing treatment adherence and outcomes
    • High demand for minimally invasive surgical techniques for treating dyskinesia
    • Expanding pipeline of novel therapeutic agents aimed at mitigating dyskinesia symptoms
  • Market Restraints
    • High costs of advanced treatments
  • Market Opportunities
    • Innovative therapeutic interventions for enhancing mobility and quality of life in dyskinesia patients
    • Advanced diagnostic tools and technologies for early detection and monitoring of dyskinesia progression
    • Personalized treatment plans integrating pharmacological and non-pharmacological approaches for dyskinesia management
  • Market Challenges
    • Adverse medication effects along with stringent regulatory requirements

Exploring Porter’s Five Forces for the Dyskinesia Market

Porter’s Five Forces framework further strengthens the insights of the Dyskinesia Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Dyskinesia Market

External macro-environmental factors deeply influence the performance of the Dyskinesia Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Dyskinesia Market

The Dyskinesia Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Dyskinesia Market

The Dyskinesia Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Dyskinesia Market

The Dyskinesia Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dyskinesia Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Acadia Pharmaceuticals Inc., Acorda Therapeutics, Inc., Adamas Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., BioArctic AB, GlaxoSmithKline plc, Intra-Cellular Therapies, Inc., Ipsen Pharma, Kyowa Kirin Co., Ltd., Lundbeck A/S, Medtronic plc, Merz Pharmaceuticals GmbH, Neurocrine Biosciences, Inc., Roche Holding AG, Sage Therapeutics, Inc., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Ultragenyx Pharmaceutical Inc., and Voyager Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the Dyskinesia Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Chorea
    • Levodopa-Induced Dyskinesia
    • Myoclonus
    • Orofacial Dyskinesia
    • Paroxysmal Dyskinesias
    • Tardive Dyskinesia
  • Treatment
    • Medications
      • Anticholinergics
      • Glutamate Blockers
      • Monoamine Transport Modifiers
    • Surgical Procedures
      • Ablative Techniques
      • Deep Brain Stimulation
    • Therapies
      • Occupational Therapy
      • Physical Therapy
      • Speech Therapy
  • Route of Administration
    • Injectable
    • Oral
    • Transdermal Patches
  • End User
    • Academic & Research Institutes
    • Homecare
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Collaborative efforts between pharmaceutical companies and research institutions
5.1.1.2. Increase in patient-centric care models enhancing treatment adherence and outcomes
5.1.1.3. High demand for minimally invasive surgical techniques for treating dyskinesia
5.1.1.4. Expanding pipeline of novel therapeutic agents aimed at mitigating dyskinesia symptoms
5.1.2. Restraints
5.1.2.1. High costs of advanced treatments
5.1.3. Opportunities
5.1.3.1. Innovative therapeutic interventions for enhancing mobility and quality of life in dyskinesia patients
5.1.3.2. Advanced diagnostic tools and technologies for early detection and monitoring of dyskinesia progression
5.1.3.3. Personalized treatment plans integrating pharmacological and non-pharmacological approaches for dyskinesia management
5.1.4. Challenges
5.1.4.1. Adverse medication effects along with stringent regulatory requirements
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Dyskinesia Market, by Type
6.1. Introduction
6.2. Chorea
6.3. Levodopa-Induced Dyskinesia
6.4. Myoclonus
6.5. Orofacial Dyskinesia
6.6. Paroxysmal Dyskinesias
6.7. Tardive Dyskinesia
7. Dyskinesia Market, by Treatment
7.1. Introduction
7.2. Medications
7.2.1. Anticholinergics
7.2.2. Glutamate Blockers
7.2.3. Monoamine Transport Modifiers
7.3. Surgical Procedures
7.3.1. Ablative Techniques
7.3.2. Deep Brain Stimulation
7.4. Therapies
7.4.1. Occupational Therapy
7.4.2. Physical Therapy
7.4.3. Speech Therapy
8. Dyskinesia Market, by Route of Administration
8.1. Introduction
8.2. Injectable
8.3. Oral
8.4. Transdermal Patches
9. Dyskinesia Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Homecare
9.4. Hospitals
9.5. Specialty Clinics
10. Americas Dyskinesia Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Dyskinesia Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Dyskinesia Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DYSKINESIA MARKET RESEARCH PROCESS
FIGURE 2. DYSKINESIA MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DYSKINESIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DYSKINESIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DYSKINESIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DYSKINESIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DYSKINESIA MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DYSKINESIA MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. DYSKINESIA MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. DYSKINESIA MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DYSKINESIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DYSKINESIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DYSKINESIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DYSKINESIA MARKET DYNAMICS
TABLE 7. GLOBAL DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DYSKINESIA MARKET SIZE, BY CHOREA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DYSKINESIA MARKET SIZE, BY LEVODOPA-INDUCED DYSKINESIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DYSKINESIA MARKET SIZE, BY MYOCLONUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DYSKINESIA MARKET SIZE, BY OROFACIAL DYSKINESIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DYSKINESIA MARKET SIZE, BY PAROXYSMAL DYSKINESIAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DYSKINESIA MARKET SIZE, BY TARDIVE DYSKINESIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DYSKINESIA MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DYSKINESIA MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DYSKINESIA MARKET SIZE, BY GLUTAMATE BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DYSKINESIA MARKET SIZE, BY MONOAMINE TRANSPORT MODIFIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DYSKINESIA MARKET SIZE, BY ABLATIVE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DYSKINESIA MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DYSKINESIA MARKET SIZE, BY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DYSKINESIA MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DYSKINESIA MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DYSKINESIA MARKET SIZE, BY SPEECH THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DYSKINESIA MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DYSKINESIA MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DYSKINESIA MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DYSKINESIA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DYSKINESIA MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DYSKINESIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DYSKINESIA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. CANADA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 62. CANADA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 63. CANADA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 64. CANADA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 65. CANADA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. CANADA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. MEXICO DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. MEXICO DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 71. MEXICO DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 72. MEXICO DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. CHINA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. CHINA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. CHINA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 100. CHINA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 101. CHINA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 102. CHINA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. CHINA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. INDIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. INDIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. INDIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 107. INDIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 108. INDIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 109. INDIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. INDIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. JAPAN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. JAPAN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 120. JAPAN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 121. JAPAN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 122. JAPAN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 123. JAPAN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. JAPAN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. THAILAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. THAILAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. THAILAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 163. THAILAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 164. THAILAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 165. THAILAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. THAILAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 182. DENMARK DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. DENMARK DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 184. DENMARK DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 185. DENMARK DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 186. DENMARK DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 187. DENMARK DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. DENMARK DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. EGYPT DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 191. EGYPT DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 192. EGYPT DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 193. EGYPT DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 194. EGYPT DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. EGYPT DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. FINLAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. FINLAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 200. FINLAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 201. FINLAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. FINLAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. FRANCE DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. FRANCE DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 205. FRANCE DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 207. FRANCE DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 208. FRANCE DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. FRANCE DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. GERMANY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. GERMANY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 212. GERMANY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 213. GERMANY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 214. GERMANY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 215. GERMANY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. GERMANY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. ITALY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. ITALY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 226. ITALY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 227. ITALY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 228. ITALY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 229. ITALY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. ITALY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. NORWAY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. NORWAY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 247. NORWAY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 249. NORWAY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 250. NORWAY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. NORWAY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. POLAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 253. POLAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 254. POLAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 255. POLAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 256. POLAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 257. POLAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 258. POLAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. QATAR DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. QATAR DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 261. QATAR DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 262. QATAR DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 263. QATAR DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 264. QATAR DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. QATAR DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. SPAIN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 288. SPAIN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 289. SPAIN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 291. SPAIN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 292. SPAIN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 293. SPAIN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. TURKEY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 309. TURKEY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 310. TURKEY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 311. TURKEY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 312. TURKEY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 313. TURKEY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. TURKEY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 328. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. DYSKINESIA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 330. DYSKINESIA MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Dyskinesia Market, which are profiled in this report, include:
  • AbbVie Inc.
  • Acadia Pharmaceuticals Inc.
  • Acorda Therapeutics, Inc.
  • Adamas Pharmaceuticals, Inc.
  • Amneal Pharmaceuticals, Inc.
  • BioArctic AB
  • GlaxoSmithKline plc
  • Intra-Cellular Therapies, Inc.
  • Ipsen Pharma
  • Kyowa Kirin Co., Ltd.
  • Lundbeck A/S
  • Medtronic plc
  • Merz Pharmaceuticals GmbH
  • Neurocrine Biosciences, Inc.
  • Roche Holding AG
  • Sage Therapeutics, Inc.
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Ultragenyx Pharmaceutical Inc.
  • Voyager Therapeutics, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.5 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.13 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Dyskinesia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Dyskinesia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Tardive Dyskinesia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Tardive Dyskinesia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Dyskinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Dyskinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 130 Pages
  • Global
From
Tardive Dyskinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Tardive Dyskinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 130 Pages
  • Global
From
Tardive Dyskinesia Therapeutics Market Analysis & Forecast to 2024-2034 - Product Image

Tardive Dyskinesia Therapeutics Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From

About the Market

Dyskinesia is a neurological disorder characterized by involuntary, repetitive movements. It is most commonly associated with the use of certain central nervous system drugs, such as antipsychotics and levodopa. Dyskinesia can cause a range of physical symptoms, including jerky movements, tremors, and difficulty with coordination. It can also lead to psychological symptoms, such as anxiety and depression. The dyskinesia market is composed of a range of pharmaceutical companies that produce drugs to treat the disorder. These companies develop and market medications that can reduce the severity of symptoms and improve quality of life. Many of these drugs are approved by the FDA and are available in both generic and brand-name forms. Some of the companies in the dyskinesia market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.